Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2006-12-12
2006-12-12
Angell, Jon (Department: 1635)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S135100, C424S139100, C424S149100, C530S351000
Reexamination Certificate
active
07147852
ABSTRACT:
Materials and methods for reducing TGF-β production and promoting repair of liver damage in a mammal are disclosed. The methods comprise administering to a mammal a composition comprising a therapeutically effective amount of an anti-zvegf3 antibody in combination with a pharmaceutically acceptable delivery vehicle.
REFERENCES:
patent: 5238950 (1993-08-01), Clader et al.
patent: 5700823 (1997-12-01), Hirth et al.
patent: 6432673 (2002-08-01), Gao et al.
patent: 6455283 (2002-09-01), Ferrara et al.
patent: 6528050 (2003-03-01), Gao et al.
patent: 6814965 (2004-11-01), Gao et al.
patent: 6893637 (2005-05-01), Gilbertson
patent: 2002/0004225 (2002-01-01), Hart et al.
patent: 2002/0177193 (2002-11-01), Gao et al.
patent: 2005/0049218 (2005-03-01), Gilbertson
patent: 2005/0191304 (2005-09-01), Palmer
patent: WO99/037671 (1999-07-01), None
patent: 99/46281 (1999-09-01), None
patent: 99/47677 (1999-09-01), None
patent: WO00/018212 (2000-04-01), None
patent: 00/34474 (2000-06-01), None
patent: 00/59940 (2000-10-01), None
Martinet et al.,New England Journal of Medicine317:202-209, 1987.
Deuel et al.,New England Journal of Medicine317: 236, 1987.
Isaka et al.,J. Clin. Invest.92: 2597-2601, 1993.
Yoshida et al.,Biochem. Biophys. Res. Comm.265: 503-508, 1999.
Johnson et al.,J. Exp. Med.175: 1413-1416, 1992.
Rice et al.,Am. J. Path.155: 213-221, 1999.
Yi et al.,Am. J. Path.149: 539-548, 1996.
Floege et al.,J. Clin. Invest.92: 2952-2962, 1993.
Li et al.,Nature Cell Biol.2: 302-309, 2000.
Bergsten et al.,Nature Cell Biol.3: 512-516, 2001.
LaRochelle et al.,Nature Cell Biol.3: 517-521, 2001.
Uutela et al.,Circulation103: 2242-2247, 2001.
Johnson et al.,J. Exp. Med.175: 1413-1416, 1992.
Preaux et al.,Hepatology26: 315-322, 1997.
Kallio et al.,Am. J. Respir. Crit. Care Med.160: 1324-1332, 1999.
Yagi et al.,Gen. Pharmac.31: 765-773, 1998.
Pinzani et al.,Brit. J. Pharmac.119: 1117-1124, 1996.
Friedman,Seminars in Liver Disease19: 129-140, 1999.
Li et al.,Journal of Gastroenterology and Hepatology14: 618-633, 1999.
Brady et al.,Biochem. Biophys. Res. Comm.248: 174-179, 1998.
Heldin et al.,Physiological Reviews79: 1283-1316, 1999.
Isbrucker et al.,Tox. App. Pharmac.149: 120-126, 1998.
Angell Jon
Parker Gary E.
ZymoGenetics Inc.
LandOfFree
Methods for reducing TGF-β production and for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for reducing TGF-β production and for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for reducing TGF-β production and for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3677604